Click for best price
Recombinant Protein Drugs Market Size, Share 2023
The global Recombinant Protein Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Recombinant Protein Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Protein Drugs. This report contains market size and forecasts of Recombinant Protein Drugs in global, including the following market information:
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Recombinant DNA Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Protein Drugs include Novo Nordisk, Amgen, Sanofi, Eli Lilly, Merck Serono, Ortho Biotech, Roche, Kyowa Hakko Kirin and Pharmingen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Protein Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Protein Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Doses)
Global Recombinant Protein Drugs Market Segment Percentages, by Type, 2022 (%)
- Recombinant DNA
- Recombinant RNA
Global Recombinant Protein Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Doses)
Global Recombinant Protein Drugs Market Segment Percentages, by Application, 2022 (%)
- Pharmaceutical Industry
- Others
Global Recombinant Protein Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Doses)
Global Recombinant Protein Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Recombinant Protein Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Recombinant Protein Drugs revenues share in global market, 2022 (%)
- Key companies Recombinant Protein Drugs sales in global market, 2018-2023 (Estimated), (K Doses)
- Key companies Recombinant Protein Drugs sales share in global market, 2022 (%)
Key players include:
- Novo Nordisk
- Amgen
- Sanofi
- Eli Lilly
- Merck Serono
- Ortho Biotech
- Roche
- Kyowa Hakko Kirin
- Pharmingen
- Abcam
- GenSci
- SL PHARM
- Dongbao Pharm
- Ankebio
- NCPC
- Heng Rui
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Protein Drugs, market overview.
Chapter 2: Global Recombinant Protein Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Protein Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Protein Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Protein Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Recombinant Protein Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
200 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Protein Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Protein Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Protein Drugs Overall Market Size
2.1 Global Recombinant Protein Drugs Market Size: 2022 VS 2032
2.2 Global Recombinant Protein Drugs Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Recombinant Protein Drugs Sales: 2018-2032
3 Company Landscape
3.1 Top Recombinant Protein Drugs Players in Global Market
3.2 Top Global Recombinant Protein Drugs Companies Ranked by Revenue
3.3 Global Recombinant Protein Drugs Revenue by Companies
3.4 Global Recombinant Protein Drugs Sales by Companies
3.5 Global Recombinant Protein Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Protein Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Protein Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Protein Drugs Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Protein Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Protein Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Protein Drugs Market Size Markets, 2022 & 2032
4.1.2 Recombinant DNA
4.1.3 Recombinant RNA
4.2 By Type - Global Recombinant Protein Drugs Revenue & Forecasts
4.2.1 By Type - Global Recombinant Protein Drugs Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Protein Drugs Revenue, 2024-2032
4.2.3 By Type - Global Recombinant Protein Drugs Revenue Market Share, 2018-2032
4.3 By Type - Global Recombinant Protein Drugs Sales & Forecasts
4.3.1 By Type - Global Recombinant Protein Drugs Sales, 2018-2023
4.3.2 By Type - Global Recombinant Protein Drugs Sales, 2024-2032
4.3.3 By Type - Global Recombinant Protein Drugs Sales Market Share, 2018-2032
4.4 By Type - Global Recombinant Protein Drugs Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Protein Drugs Market Size, 2022 & 2032
5.1.2 Pharmaceutical Industry
5.1.3 Others
5.2 By Application - Global Recombinant Protein Drugs Revenue & Forecasts
5.2.1 By Application - Global Recombinant Protein Drugs Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Protein Drugs Revenue, 2024-2032
5.2.3 By Application - Global Recombinant Protein Drugs Revenue Market Share, 2018-2032
5.3 By Application - Global Recombinant Protein Drugs Sales & Forecasts
5.3.1 By Application - Global Recombinant Protein Drugs Sales, 2018-2023
5.3.2 By Application - Global Recombinant Protein Drugs Sales, 2024-2032
5.3.3 By Application - Global Recombinant Protein Drugs Sales Market Share, 2018-2032
5.4 By Application - Global Recombinant Protein Drugs Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Recombinant Protein Drugs Market Size, 2022 & 2032
6.2 By Region - Global Recombinant Protein Drugs Revenue & Forecasts
6.2.1 By Region - Global Recombinant Protein Drugs Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Protein Drugs Revenue, 2024-2032
6.2.3 By Region - Global Recombinant Protein Drugs Revenue Market Share, 2018-2032
6.3 By Region - Global Recombinant Protein Drugs Sales & Forecasts
6.3.1 By Region - Global Recombinant Protein Drugs Sales, 2018-2023
6.3.2 By Region - Global Recombinant Protein Drugs Sales, 2024-2032
6.3.3 By Region - Global Recombinant Protein Drugs Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Recombinant Protein Drugs Revenue, 2018-2032
6.4.2 By Country - North America Recombinant Protein Drugs Sales, 2018-2032
6.4.3 US Recombinant Protein Drugs Market Size, 2018-2032
6.4.4 Canada Recombinant Protein Drugs Market Size, 2018-2032
6.4.5 Mexico Recombinant Protein Drugs Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Recombinant Protein Drugs Revenue, 2018-2032
6.5.2 By Country - Europe Recombinant Protein Drugs Sales, 2018-2032
6.5.3 Germany Recombinant Protein Drugs Market Size, 2018-2032
6.5.4 France Recombinant Protein Drugs Market Size, 2018-2032
6.5.5 U.K. Recombinant Protein Drugs Market Size, 2018-2032
6.5.6 Italy Recombinant Protein Drugs Market Size, 2018-2032
6.5.7 Russia Recombinant Protein Drugs Market Size, 2018-2032
6.5.8 Nordic Countries Recombinant Protein Drugs Market Size, 2018-2032
6.5.9 Benelux Recombinant Protein Drugs Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Recombinant Protein Drugs Revenue, 2018-2032
6.6.2 By Region - Asia Recombinant Protein Drugs Sales, 2018-2032
6.6.3 China Recombinant Protein Drugs Market Size, 2018-2032
6.6.4 Japan Recombinant Protein Drugs Market Size, 2018-2032
6.6.5 South Korea Recombinant Protein Drugs Market Size, 2018-2032
6.6.6 Southeast Asia Recombinant Protein Drugs Market Size, 2018-2032
6.6.7 India Recombinant Protein Drugs Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Recombinant Protein Drugs Revenue, 2018-2032
6.7.2 By Country - South America Recombinant Protein Drugs Sales, 2018-2032
6.7.3 Brazil Recombinant Protein Drugs Market Size, 2018-2032
6.7.4 Argentina Recombinant Protein Drugs Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Protein Drugs Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Recombinant Protein Drugs Sales, 2018-2032
6.8.3 Turkey Recombinant Protein Drugs Market Size, 2018-2032
6.8.4 Israel Recombinant Protein Drugs Market Size, 2018-2032
6.8.5 Saudi Arabia Recombinant Protein Drugs Market Size, 2018-2032
6.8.6 UAE Recombinant Protein Drugs Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Recombinant Protein Drugs Major Product Offerings
7.1.4 Novo Nordisk Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novo Nordisk Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Recombinant Protein Drugs Major Product Offerings
7.2.4 Amgen Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Recombinant Protein Drugs Major Product Offerings
7.3.4 Sanofi Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Recombinant Protein Drugs Major Product Offerings
7.4.4 Eli Lilly Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Merck Serono
7.5.1 Merck Serono Company Summary
7.5.2 Merck Serono Business Overview
7.5.3 Merck Serono Recombinant Protein Drugs Major Product Offerings
7.5.4 Merck Serono Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck Serono Key News & Latest Developments
7.6 Ortho Biotech
7.6.1 Ortho Biotech Company Summary
7.6.2 Ortho Biotech Business Overview
7.6.3 Ortho Biotech Recombinant Protein Drugs Major Product Offerings
7.6.4 Ortho Biotech Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Ortho Biotech Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Recombinant Protein Drugs Major Product Offerings
7.7.4 Roche Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 Kyowa Hakko Kirin
7.8.1 Kyowa Hakko Kirin Company Summary
7.8.2 Kyowa Hakko Kirin Business Overview
7.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Major Product Offerings
7.8.4 Kyowa Hakko Kirin Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Kyowa Hakko Kirin Key News & Latest Developments
7.9 Pharmingen
7.9.1 Pharmingen Company Summary
7.9.2 Pharmingen Business Overview
7.9.3 Pharmingen Recombinant Protein Drugs Major Product Offerings
7.9.4 Pharmingen Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Pharmingen Key News & Latest Developments
7.10 Abcam
7.10.1 Abcam Company Summary
7.10.2 Abcam Business Overview
7.10.3 Abcam Recombinant Protein Drugs Major Product Offerings
7.10.4 Abcam Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Abcam Key News & Latest Developments
7.11 GenSci
7.11.1 GenSci Company Summary
7.11.2 GenSci Recombinant Protein Drugs Business Overview
7.11.3 GenSci Recombinant Protein Drugs Major Product Offerings
7.11.4 GenSci Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.11.5 GenSci Key News & Latest Developments
7.12 SL PHARM
7.12.1 SL PHARM Company Summary
7.12.2 SL PHARM Recombinant Protein Drugs Business Overview
7.12.3 SL PHARM Recombinant Protein Drugs Major Product Offerings
7.12.4 SL PHARM Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.12.5 SL PHARM Key News & Latest Developments
7.13 Dongbao Pharm
7.13.1 Dongbao Pharm Company Summary
7.13.2 Dongbao Pharm Recombinant Protein Drugs Business Overview
7.13.3 Dongbao Pharm Recombinant Protein Drugs Major Product Offerings
7.13.4 Dongbao Pharm Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Dongbao Pharm Key News & Latest Developments
7.14 Ankebio
7.14.1 Ankebio Company Summary
7.14.2 Ankebio Business Overview
7.14.3 Ankebio Recombinant Protein Drugs Major Product Offerings
7.14.4 Ankebio Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Ankebio Key News & Latest Developments
7.15 NCPC
7.15.1 NCPC Company Summary
7.15.2 NCPC Business Overview
7.15.3 NCPC Recombinant Protein Drugs Major Product Offerings
7.15.4 NCPC Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.15.5 NCPC Key News & Latest Developments
7.16 Heng Rui
7.16.1 Heng Rui Company Summary
7.16.2 Heng Rui Business Overview
7.16.3 Heng Rui Recombinant Protein Drugs Major Product Offerings
7.16.4 Heng Rui Recombinant Protein Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Heng Rui Key News & Latest Developments
8 Global Recombinant Protein Drugs Production Capacity, Analysis
8.1 Global Recombinant Protein Drugs Production Capacity, 2018-2032
8.2 Recombinant Protein Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Protein Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Protein Drugs Supply Chain Analysis
10.1 Recombinant Protein Drugs Industry Value Chain
10.2 Recombinant Protein Drugs Upstream Market
10.3 Recombinant Protein Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Protein Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Protein Drugs in Global Market
Table 2. Top Recombinant Protein Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Protein Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Protein Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Protein Drugs Sales by Companies, (K Doses), 2018-2023
Table 6. Global Recombinant Protein Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Protein Drugs Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Recombinant Protein Drugs Product Type
Table 9. List of Global Tier 1 Recombinant Protein Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Protein Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Protein Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Recombinant Protein Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Protein Drugs Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Recombinant Protein Drugs Sales (K Doses), 2018-2023
Table 15. By Type - Global Recombinant Protein Drugs Sales (K Doses), 2024-2032
Table 16. By Application ? Global Recombinant Protein Drugs Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Recombinant Protein Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Protein Drugs Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Recombinant Protein Drugs Sales (K Doses), 2018-2023
Table 20. By Application - Global Recombinant Protein Drugs Sales (K Doses), 2024-2032
Table 21. By Region ? Global Recombinant Protein Drugs Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Recombinant Protein Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Protein Drugs Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Recombinant Protein Drugs Sales (K Doses), 2018-2023
Table 25. By Region - Global Recombinant Protein Drugs Sales (K Doses), 2024-2032
Table 26. By Country - North America Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Protein Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Recombinant Protein Drugs Sales, (K Doses), 2018-2023
Table 29. By Country - North America Recombinant Protein Drugs Sales, (K Doses), 2024-2032
Table 30. By Country - Europe Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Protein Drugs Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Recombinant Protein Drugs Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Recombinant Protein Drugs Sales, (K Doses), 2024-2032
Table 34. By Region - Asia Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Protein Drugs Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Recombinant Protein Drugs Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Recombinant Protein Drugs Sales, (K Doses), 2024-2032
Table 38. By Country - South America Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Protein Drugs Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Recombinant Protein Drugs Sales, (K Doses), 2018-2023
Table 41. By Country - South America Recombinant Protein Drugs Sales, (K Doses), 2024-2032
Table 42. By Country - Middle East & Africa Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Protein Drugs Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Recombinant Protein Drugs Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Protein Drugs Sales, (K Doses), 2024-2032
Table 46. Novo Nordisk Company Summary
Table 47. Novo Nordisk Recombinant Protein Drugs Product Offerings
Table 48. Novo Nordisk Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Novo Nordisk Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Recombinant Protein Drugs Product Offerings
Table 52. Amgen Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Recombinant Protein Drugs Product Offerings
Table 56. Sanofi Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Recombinant Protein Drugs Product Offerings
Table 60. Eli Lilly Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Eli Lilly Key News & Latest Developments
Table 62. Merck Serono Company Summary
Table 63. Merck Serono Recombinant Protein Drugs Product Offerings
Table 64. Merck Serono Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Merck Serono Key News & Latest Developments
Table 66. Ortho Biotech Company Summary
Table 67. Ortho Biotech Recombinant Protein Drugs Product Offerings
Table 68. Ortho Biotech Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Ortho Biotech Key News & Latest Developments
Table 70. Roche Company Summary
Table 71. Roche Recombinant Protein Drugs Product Offerings
Table 72. Roche Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Roche Key News & Latest Developments
Table 74. Kyowa Hakko Kirin Company Summary
Table 75. Kyowa Hakko Kirin Recombinant Protein Drugs Product Offerings
Table 76. Kyowa Hakko Kirin Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Kyowa Hakko Kirin Key News & Latest Developments
Table 78. Pharmingen Company Summary
Table 79. Pharmingen Recombinant Protein Drugs Product Offerings
Table 80. Pharmingen Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. Pharmingen Key News & Latest Developments
Table 82. Abcam Company Summary
Table 83. Abcam Recombinant Protein Drugs Product Offerings
Table 84. Abcam Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. Abcam Key News & Latest Developments
Table 86. GenSci Company Summary
Table 87. GenSci Recombinant Protein Drugs Product Offerings
Table 88. GenSci Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 89. GenSci Key News & Latest Developments
Table 90. SL PHARM Company Summary
Table 91. SL PHARM Recombinant Protein Drugs Product Offerings
Table 92. SL PHARM Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 93. SL PHARM Key News & Latest Developments
Table 94. Dongbao Pharm Company Summary
Table 95. Dongbao Pharm Recombinant Protein Drugs Product Offerings
Table 96. Dongbao Pharm Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 97. Dongbao Pharm Key News & Latest Developments
Table 98. Ankebio Company Summary
Table 99. Ankebio Recombinant Protein Drugs Product Offerings
Table 100. Ankebio Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 101. Ankebio Key News & Latest Developments
Table 102. NCPC Company Summary
Table 103. NCPC Recombinant Protein Drugs Product Offerings
Table 104. NCPC Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 105. NCPC Key News & Latest Developments
Table 106. Heng Rui Company Summary
Table 107. Heng Rui Recombinant Protein Drugs Product Offerings
Table 108. Heng Rui Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 109. Heng Rui Key News & Latest Developments
Table 110. Recombinant Protein Drugs Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 111. Global Recombinant Protein Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Recombinant Protein Drugs Production by Region, 2018-2023 (K Doses)
Table 113. Global Recombinant Protein Drugs Production by Region, 2024-2032 (K Doses)
Table 114. Recombinant Protein Drugs Market Opportunities & Trends in Global Market
Table 115. Recombinant Protein Drugs Market Drivers in Global Market
Table 116. Recombinant Protein Drugs Market Restraints in Global Market
Table 117. Recombinant Protein Drugs Raw Materials
Table 118. Recombinant Protein Drugs Raw Materials Suppliers in Global Market
Table 119. Typical Recombinant Protein Drugs Downstream
Table 120. Recombinant Protein Drugs Downstream Clients in Global Market
Table 121. Recombinant Protein Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Protein Drugs Segment by Type in 2022
Figure 2. Recombinant Protein Drugs Segment by Application in 2022
Figure 3. Global Recombinant Protein Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Protein Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Recombinant Protein Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. Recombinant Protein Drugs Sales in Global Market: 2018-2032 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Protein Drugs Revenue in 2022
Figure 9. By Type - Global Recombinant Protein Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Recombinant Protein Drugs Revenue Market Share, 2018-2032
Figure 11. By Type - Global Recombinant Protein Drugs Sales Market Share, 2018-2032
Figure 12. By Type - Global Recombinant Protein Drugs Price (USD/Dose), 2018-2032
Figure 13. By Application - Global Recombinant Protein Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Recombinant Protein Drugs Revenue Market Share, 2018-2032
Figure 15. By Application - Global Recombinant Protein Drugs Sales Market Share, 2018-2032
Figure 16. By Application - Global Recombinant Protein Drugs Price (USD/Dose), 2018-2032
Figure 17. By Region - Global Recombinant Protein Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Recombinant Protein Drugs Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Recombinant Protein Drugs Revenue Market Share, 2018-2032
Figure 20. By Region - Global Recombinant Protein Drugs Sales Market Share, 2018-2032
Figure 21. By Country - North America Recombinant Protein Drugs Revenue Market Share, 2018-2032
Figure 22. By Country - North America Recombinant Protein Drugs Sales Market Share, 2018-2032
Figure 23. US Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Recombinant Protein Drugs Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Recombinant Protein Drugs Sales Market Share, 2018-2032
Figure 28. Germany Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. France Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Recombinant Protein Drugs Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Recombinant Protein Drugs Sales Market Share, 2018-2032
Figure 37. China Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. India Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Recombinant Protein Drugs Revenue Market Share, 2018-2032
Figure 43. By Country - South America Recombinant Protein Drugs Sales Market Share, 2018-2032
Figure 44. Brazil Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Recombinant Protein Drugs Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Recombinant Protein Drugs Sales Market Share, 2018-2032
Figure 48. Turkey Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Recombinant Protein Drugs Revenue, (US$, Mn), 2018-2032
Figure 52. Global Recombinant Protein Drugs Production Capacity (K Doses), 2018-2032
Figure 53. The Percentage of Production Recombinant Protein Drugs by Region, 2022 VS 2032
Figure 54. Recombinant Protein Drugs Industry Value Chain
Figure 55. Marketing Channels
